Articles

Apellis will seek re-examination from the CHMP following the opinion

Management of neovascular glaucoma focuses on decreasing retinal ischemia through panretinal photocoagulation and the injection of anti-VEGF agents

A preview of presentations from 4D Molecular Therapeutics and Adverum Biotechnologies

The YOSEMITE/RHINE studies measured changes in the BCVA and CST from baseline to years 1 and 2

The prize, presented by EURETINA and supported by Oculis, will recognise outstanding contributions to retina research

The adaptor was tested by low-vision patients and participants with simulated visual impairment

The diagnostic and monitoring tools use artificial intelligence-based models

Ophthalmologists graded AI bots' answers to questions from patients following cataract surgery

The US Food and Drug Administration issued designations for the allogeneic cell therapy candidate, a therapeutic for corneal oedema

Sustainability, artificial intelligence and economic considerations are hot topics at this year’s meeting

XLRP often leads to blindness by middle age with no treatment options currently available

Investigators say the discovery highlights the importance of genetic consultation

The mapping method revealed prominent microscopic abnormalities consistent with DR

Paying attention to high-resolution OCT is more important than ever

The NP-1/NP-1C preloaded IOL injector has already been made available in parts of Asia

Metabolomics reflects the physiological state of a tissue and provides information about interactions between genetics, environment and lifestyle

Simply slowing disease progression is no longer enough

ARVO attendees took a deep dive into trends and explored the near future of vision science

Study could influence screening protocols for neonatal patients

Investigators put forth a list of considerations for surgeons ahead of lens removalin paediatric patients

Plasma emission can act as a therapeutic for blepharitis, dry eye and other ocular disease

Investigators reported findings from the first study of successful macular hole closure using topical therapy

Investigators assessed the XEN45 implant alone and in combination with phacoemulsification

Early results indicate that trained optometrists delivered safe and effective laser treatments

The flagship, light-based technology has received approval for applications in the anterior and posterior segments

Surgeons shared practical pearls in a “Cataract Olympiad"

This year’s meeting will take place in Ireland’s technology and business hub

Three approaches to examination give a comprehensive overview

The approval also grants Outlook Therapeutics an initial 10 years of market exclusivity in the EU for bevacizumab gamma (LYTENAVA)